Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Non-controlling Interest	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022		209,684,548
Beginning balance at Dec. 31, 2022	$ 401,682	$ 21	$ 1,972,006	$ (1,558,088)	$ (11,662)	$ (595)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)		71,444,729
Issuance of common stock, net of offering costs	106,057	$ 7	106,050
Exercise of stock options (in shares)		28,663
Exercise of stock options	46		46
Cancellation of escrow shares in connection with Edisn acquisition (in shares)		(12,595)
Cancellation of escrow shares in connection with Edisn acquisition	(344)		(344)
Delivery of common stock underlying restricted stock units (in shares)		454,462
Stock-based compensation	11,738		11,738
Molotov non-controlling interest	(499)		(864)		374	(9)
Foreign currency translation adjustment	2,756					2,756
Net loss attributable to non-controlling interest	(11)				(11)
Net loss attributable to common shareholders	(83,613)			(83,613)
Ending balance (in shares) at Mar. 31, 2023		281,599,807
Ending balance at Mar. 31, 2023	437,812	$ 28	2,088,632	(1,641,701)	(11,299)	2,152
Beginning balance (in shares) at Dec. 31, 2022		209,684,548
Beginning balance at Dec. 31, 2022	401,682	$ 21	1,972,006	(1,558,088)	(11,662)	(595)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss attributable to non-controlling interest	(26)
Net loss attributable to common shareholders	(217,364)
Ending balance (in shares) at Sep. 30, 2023		292,778,171
Ending balance at Sep. 30, 2023	333,436	$ 29	2,121,742	(1,775,452)	(11,314)	(1,569)
Beginning balance (in shares) at Mar. 31, 2023		281,599,807
Beginning balance at Mar. 31, 2023	437,812	$ 28	2,088,632	(1,641,701)	(11,299)	2,152
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)		10,250,000
Issuance of common stock, net of offering costs	10,855	$ 1	10,854
Exercise of stock options (in shares)		161,825
Exercise of stock options	49		49
Delivery of common stock underlying restricted stock units (in shares)		547,493
Stock-based compensation	11,211		11,211
Foreign currency translation adjustment	137					137
Net loss attributable to non-controlling interest	(10)				(10)
Net loss attributable to common shareholders	(49,940)			(49,940)
Ending balance (in shares) at Jun. 30, 2023		292,559,125
Ending balance at Jun. 30, 2023	410,114	$ 29	2,110,746	(1,691,641)	(11,309)	2,289
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs	(9)		(9)
Exercise of stock options (in shares)		82,547
Exercise of stock options	164		164
Delivery of common stock underlying restricted stock units (in shares)		136,499
Stock-based compensation	10,841		10,841
Foreign currency translation adjustment	(3,858)					(3,858)
Net loss attributable to non-controlling interest	(5)				(5)
Net loss attributable to common shareholders	(83,811)			(83,811)
Ending balance (in shares) at Sep. 30, 2023		292,778,171
Ending balance at Sep. 30, 2023	$ 333,436	$ 29	2,121,742	(1,775,452)	(11,314)	(1,569)
Beginning balance (in shares) at Dec. 31, 2023	299,215,160	299,215,160
Beginning balance at Dec. 31, 2023	$ 283,825	$ 30	2,136,870	(1,845,542)	(11,751)	4,218
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		2,042
Exercise of stock options	2		2
Delivery of common stock underlying restricted stock units (in shares)		507,198
Stock-based compensation	11,873		11,873
Foreign currency translation adjustment	(3,015)					(3,015)
Net loss attributable to non-controlling interest	(574)				(574)
Net loss attributable to common shareholders	(56,010)			(56,010)
Ending balance (in shares) at Mar. 31, 2024		299,724,400
Ending balance at Mar. 31, 2024	$ 236,101	$ 30	2,148,745	(1,901,552)	(12,325)	1,203
Beginning balance (in shares) at Dec. 31, 2023	299,215,160	299,215,160
Beginning balance at Dec. 31, 2023	$ 283,825	$ 30	2,136,870	(1,845,542)	(11,751)	4,218
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	4,042
Net loss attributable to non-controlling interest	$ (1,454)
Net loss attributable to common shareholders	$ (133,705)
Ending balance (in shares) at Sep. 30, 2024	334,092,630	334,092,630
Ending balance at Sep. 30, 2024	$ 222,227	$ 33	2,209,993	(1,979,247)	(13,205)	4,653
Beginning balance (in shares) at Mar. 31, 2024		299,724,400
Beginning balance at Mar. 31, 2024	236,101	$ 30	2,148,745	(1,901,552)	(12,325)	1,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)		28,791,969
Issuance of common stock, net of offering costs	36,838	$ 3	36,835
Exercise of stock options (in shares)		2,000
Exercise of stock options	1		1
Delivery of common stock underlying restricted stock units (in shares)		818,252
Stock-based compensation	9,385		9,385
Foreign currency translation adjustment	(2,367)					(2,367)
Net loss attributable to non-controlling interest	(455)				(455)
Net loss attributable to common shareholders	(25,272)			(25,272)
Ending balance (in shares) at Jun. 30, 2024		329,336,621
Ending balance at Jun. 30, 2024	254,231	$ 33	2,194,966	(1,926,824)	(12,780)	(1,164)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)		4,426,882
Issuance of common stock, net of offering costs	6,472		6,472
Delivery of common stock underlying restricted stock units (in shares)		329,127
Stock-based compensation	8,555		8,555
Foreign currency translation adjustment	5,817					5,817
Net loss attributable to non-controlling interest	(425)				(425)
Net loss attributable to common shareholders	$ (52,423)			(52,423)
Ending balance (in shares) at Sep. 30, 2024	334,092,630	334,092,630
Ending balance at Sep. 30, 2024	$ 222,227	$ 33	$ 2,209,993	$ (1,979,247)	$ (13,205)	$ 4,653